News blog

Avacta Group

  • BY: Andrew Hore |
  • POSTED: 22/12/2011 |

Diagnostic technology developer Avacta Group is acquiring Aptuscan for £1.48m in shares.

The shares are being issued at 0.65p each. Avacta is also raising £5.13m (£4.83m net) at 0.5p a share. Shares in Avacta fell 0.16p to 0.62p, which values the existing share capital at £10.4m.

IP Group is a major shareholder in Avacta and Aptuscan.

The cash will be used to invest in Aptuscan’s non-antibody affinity protein reagents, accelerate the expansion of the range of tests for the AX-1 animal healthcare diagnostics instruments and develop other new products.

The acquisition will help Avacts to enter the protein microarrays market for high throughput drug/biomarker discovery and new applications for human health diagnostics.

Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFDecember2011_27.pdf

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds